| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.9 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.9 |